Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jul 14, 2008; 14(26): 4127-4130
Published online Jul 14, 2008. doi: 10.3748/wjg.14.4127
Published online Jul 14, 2008. doi: 10.3748/wjg.14.4127
Item (daily sum per week) | Weighting factor |
Number of liquid or very soft stools | 2 |
Abdominal pain score in one week (rating, 0-3) | 5 |
General well-being (rating, 1-4) | 7 |
Sum of physical findings per week: | 20 |
Arthritis/arthralgia | |
Mucocutaneous lesions (e.g. erythema nodosum, aphthous ulcers) | |
Iritis/uveitis | |
Anal disease (fissure, fistula, etc) | |
External fistula (enterocutaneous, vesicle, vaginal, etc) | |
Fever over 37.8°C | |
Antidiarrheal use (e.g. diphenoxylate) | 30 |
Abdominal mass (no = 0, equivocal = 2, yes = 5) | 10 |
47 minus hematocrit (males) or 42 minus hematocrit (females) | 6 |
1-x (1-body weight divided by a standard weight) | 1 |
- Citation: Freeman HJ. Use of the Crohn’s disease activity index in clinical trials of biological agents. World J Gastroenterol 2008; 14(26): 4127-4130
- URL: https://www.wjgnet.com/1007-9327/full/v14/i26/4127.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.4127